Travere Therapeutics, Inc.

Historical 13F Holders

Symbol
TVTX
CUSIP
89422G107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 262 101 M $2.42 B
2025 Q2 227 102 M $1.50 B
2025 Q1 236 98.1 M $1.77 B
2024 Q4 213 95.2 M $1.66 B
2024 Q3 192 83.6 M $1.17 B
2024 Q2 183 92.4 M $772 M
2024 Q1 189 95.3 M $735 M
2023 Q4 182 91.7 M $825 M
2023 Q3 195 82.5 M $738 M
2023 Q2 180 82.8 M $1.27 B
2023 Q1 182 84.2 M $1.90 B
2022 Q4 165 77.2 M $1.62 B
2022 Q3 182 74.0 M $1.82 B
2022 Q2 180 69.7 M $1.69 B
2022 Q1 180 70.6 M $1.81 B
2021 Q4 190 67.8 M $2.10 B
2021 Q3 160 60.9 M $1.48 B
2021 Q2 147 63.2 M $930 M
2021 Q1 159 65.9 M $1.65 B
2020 Q4 151 53.5 M $1.46 B